GeneDx Holdings Corp. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 53.3 million compared to USD 83.23 million a year ago. Net loss was USD 42.29 million compared to USD 77.58 million a year ago. Basic loss per share from continuing operations was USD 1.64 compared to USD 6.72 a year ago.
For the nine months, revenue was USD 145.15 million compared to USD 173.34 million a year ago. Net loss was USD 149.99 million compared to USD 240.22 million a year ago. Basic loss per share from continuing operations was USD 6.31 compared to USD 24.66 a year ago.